Telehealth has made it ordinary to meet a patient by video. Prescribing controlled substances during those visits sits inside a separate set of rules, and that set has been changing for several years running.

This guide is a plain-language orientation to how those rules are usually framed. It looks at the in-person evaluation expectation, the temporary flexibilities that have shaped recent practice, and where a registered place of practice fits.

Because this is an area in transition, nothing here should be read as a settled mandate or as legal advice. Treat it as a map of the questions to ask, and confirm the current requirements with your own counsel and the relevant boards before you prescribe.

How Telemedicine Prescribing Is Framed

Two layers tend to govern any controlled-substances prescription. State controlled-substances law sets who may prescribe and from where, and federal law adds a parallel registration and a set of conditions for prescribing without seeing a patient in person.

Telemedicine does not remove either layer. It changes how the visit happens, not whether the underlying authority and its conditions apply, so the same questions you would ask for an in-office prescription still apply for one written over video.

Reading the rules this way keeps the picture clear. The questions are who is authorized, from what registered location, and on what conditions a controlled substance may be prescribed when the patient is seen remotely.

The In-Person Evaluation Expectation

Federal law has long carried an expectation that a controlled substance is prescribed in connection with an in-person medical evaluation, with telemedicine treated as a defined set of circumstances rather than an open exception. The aim of that framing is to tie remote prescribing to a genuine clinical relationship.

What that expectation requires in any given moment has not stayed fixed. The precise conditions, exceptions, and timelines have shifted through rulemaking and temporary measures, so the safest reading is that an in-person evaluation may be expected and that the details depend on current rules.

None of these questions has a single permanent answer, which is the point. Treat the in-person evaluation as an expectation to verify each time rather than a box that is permanently ticked or permanently waived.

An Area Still in Transition

Recent years have seen temporary flexibilities that broadened remote prescribing under defined conditions, followed by proposed rules and a series of extensions as a more permanent framework was worked out. The effect is that the operative rules have changed more than once in a short span.

For a prescriber, the practical lesson is humility about timelines. A practice that was permitted under a temporary measure may narrow when that measure lapses or is replaced, and the reverse can also happen, so what was true last year is not automatically true today.

One thing has stayed steady through the changes. Whatever the in-person and remote conditions are at a given moment, the prescription is still anchored to an authorized prescriber and a registered place of practice, and that anchor is where a registered office address comes in.

State Authority Still Comes First

Telehealth can make the federal questions feel like the whole story, but the sequence does not change. A state controlled-substances registration comes first, establishing your authority and your place of practice within that state, and the federal DEA registration follows.

That order holds whether the patient is in the room or on a screen. Our DEA Registration guide walks through the single-state version of this sequence, and the Multi-State Prescribing guide covers what happens when you repeat it in more than one state.

State first, then federal, then the telemedicine conditions on top. Holding that order in mind keeps a telehealth practice from skipping the registration groundwork that every controlled-substances prescription still rests on.

Where a Registered Place of Practice Fits

Even a practice run entirely by video registers to a physical location. That registered address is the place the state and the DEA associate with your authority to prescribe, and it can be subject to inspection regardless of how your visits happen.

This is why a mailbox does not work. A P.O. Box or a virtual mailbox is a place to receive mail, not a place of practice, and listing one can stall or undermine a registration that a telehealth visit otherwise relies on.

What a registered address does not do is decide your eligibility or settle the telemedicine conditions for you. It is designed to meet the physical-address requirement under 21 CFR 1301.12(a), with your use of the space and each board's approval completing the picture.

Staying Current as the Rules Change

Because this framework keeps moving, a telehealth prescriber benefits from a habit rather than a single answer. The goal is to notice when a rule shifts before it affects a prescription, not after.

A few practices make that easier. Keep a current read of the federal telemedicine rules and your patients' state requirements, and revisit them whenever you start a new prescribing pattern or enter a new state.

1. Confirm the present rule, not last year's: Treat the in-person evaluation expectation and any flexibilities as something to verify as of today, since temporary measures and rulemaking can change them.
2. Check both states involved: The patient's state and your place of practice can each impose conditions, so look at both rather than assuming one covers the other.
3. Keep registrations and addresses aligned: Make sure your state and federal registrations name the same registered place of practice, formatted consistently across your filings.
4. Lean on your own counsel: For anything close to the line, confirm with your attorney and the relevant boards rather than relying on an explainer like this one.

Conclusion & Next Steps

Telemedicine changes how a controlled-substances visit happens, not the questions underneath it. State authority comes first, the federal registration follows, and the telemedicine conditions sit on top in a form that has been revised more than once.

Through all of it, the prescription is anchored to a registered place of practice. A registered commercial office address is designed to meet the physical-address requirement under 21 CFR 1301.12(a), and the DEA-Compliant Office page lays out Basic and Practice in full when you are ready.

Frequently Asked Questions